✦ LIBER ✦

Pharmacokinetics and Safety of Once-Daily Intravenous Busulfan with Bortezomib in Patients with Relapsed Multiple Myeloma Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation

✍ Scribed by C.O. Freytes; J.J. Toro; R.F. Yeh; E.A. Stadtmauer; V. Ratanatharathorn; G. Akpek; E. Sahovic; G.J. Tricot; P.J. Shaughnessy; D.J. White; T.E. Rodriguez; S.R. Solomon; L. Yu; S. Patil; Y. Sun; E. Armstrong; A. Elekes; K. Kato; D.E. Reece

Book ID: 116282968
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 61 KB
Volume: 18
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2011.12.144

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Efficacy From Intravenous Bus

Safety and Efficacy From Intravenous Busulfan with PK-Directed Dosed Adjustment and Bortezomib Conditioning Regimen in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation

✍ Ratanatharathorn, Voravit; Stadtmauer, Edward A.; Yeh, Rosa F.; Freytes, Cesar O 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Bortezomib does not adversely affect ste

Bortezomib does not adversely affect stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation

✍ G.L. Uy; N.M. Fisher; S.M. Devine; D.R. Adkins; M.H. Tomasson; T.A. Graubert; J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Safety of autologous hematopoietic stem

Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure

✍ Tosi, P; Zamagni, E; Ronconi, S; Benni, M; Motta, M R; Rizzi, S; Tura, S; Cavo, 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB

Pharmacokinetic and Pharmcodynamic Monit

Pharmacokinetic and Pharmcodynamic Monitoring of Once Daily Intravenous Busulfan in Pediatric Patients Receiving Hematopoietic Stem Cells Transplant: A Single Instutution Experience

✍ J.C. Tse; B. Brown; T.B. Moore 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Evaluation of safety and pharmacokinetic

Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice-daily or daily schedule to patients with advanced hematologic malignant disease undergoing stem cell transplantation

✍ Hugo F Fernandez; Hai T Tran; Federico Albrecht; Shari Lennon; Humberto Caldera; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Outcome of Patients With IgD and IgM Mul

Outcome of Patients With IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Retrospective CIBMTR Study

✍ Donna E. Reece; David H. Vesole; Smriti Shrestha; Mei-Jie Zhang; Waleska S. Pére 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 820 KB